Incretin Regulation of Insulin Secretion in Monogenic Diabetes
NCT01795144
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
10
Enrollment
OTHER
Sponsor class
Conditions
Monogenic Diabetes
Interventions
DRUG:
GLP-1
DRUG:
Exendin 9-39
Sponsor
University of Chicago